Neovascularization of bone marrow in patients with diffuse multiple myeloma - A correlative study of magnetic resonance imaging and histopathologic findings

被引:37
|
作者
Baur, A
Bartl, R
Pellengahr, C
Baltin, V
Reiser, M
机构
[1] Univ Munich, Dept Clin Radiol, D-81377 Munich, Germany
[2] Univ Munich, Dept Haematol & Oncol, D-81377 Munich, Germany
[3] Univ Munich, Dept Orthopaed Surg, D-81377 Munich, Germany
关键词
multiple myeloma; magnetic resonance imaging; angiogenesis; microvessel density; gadolinium; bone marrow;
D O I
10.1002/cncr.20697
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The goal of the current study was to assess the correlation between bone marrow histology and contrast enhancement in infiltrative diffuse myeloma. METHODS. Forty-four patients with homogeneous diffuse infiltration of bone marrow by multiple myeloma were examined using magnetic resonance imaging of the spine. The sequence protocol included T1-weighted spin-echo (pre- and post-gadolinium dimeglumine administration) and short-inversion time inversion recovery sequences. The percent increase in signal after intravenous gadolinium administration was calculated in bone marrow from patients with myeloma and from a control group of 86 patients who did not have bone marrow disease. Grade of infiltration with plasma cells, fat cell content, and hematopoietic marrow content were evaluated via histologic assessment of bone marrow, and microvessel density was evaluated via anti-CD34-positive immunostaining. RESULTS. increased microvessel density was observed in association with increasing plasma cell content (Kruskall-Wallis test: P < 0.0001). Contrast enhancement increased in a stepwise manner according to grade of microvessel density (Mann-Whitney U test: P < 0.05 and P < 0.001 for increases from low to intermediate and intermediate to high grade) and was significantly higher in patients with myeloma compared with control patients (Mann-Whitney U test: P < 0.001). A significant correlation also was found between histologic extent of tumor infiltration and contrast enhancement (Mann-Whitney U test: P < 0.0001). The mean level of contrast enhancement was 18% in the control group, 26% in patients with lowgrade infiltration, 49% in patients with intermediate-grade infiltration, and 90% in patients with high-grade infiltration. In addition, fat cell content was found to be inversely correlated with contrast enhancement (chi-square test: P < 0.01). CONCLUSIONS. As a consequence of increased microvessel density, decreased fat cell content, and increased cellularity, the presence of diffuse bone marrow infiltration in patients with multiple myeloma can be verified using gadolinium-enhanced magnetic resonance imaging. (C) 2004 American Cancer Society.
引用
收藏
页码:2599 / 2604
页数:6
相关论文
共 50 条
  • [1] Magnetic resonance imaging of the bone marrow: Malignant lymphoma - Multiple myeloma - Bone marrow transplantation
    Golder, W
    ONKOLOGIE, 1999, 22 (05): : 388 - 394
  • [2] Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma
    Moulopoulos, LA
    Gika, D
    Anagnostopoulos, A
    Delasalle, K
    Weber, D
    Alexanian, R
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2005, 16 (11) : 1824 - 1828
  • [3] BILATERAL MEDIAL MEDULLARY INFARCTION - MAGNETIC-RESONANCE-IMAGING AND CORRELATIVE HISTOPATHOLOGIC FINDINGS
    KLEINERT, G
    FAZEKAS, F
    KLEINERT, R
    SCHMIDT, R
    PAYER, F
    OFFENBACHER, H
    LECHNER, H
    EUROPEAN NEUROLOGY, 1993, 33 (01) : 74 - 76
  • [4] Bone marrow imaging of bone marrow transplanted multiple myeloma patients
    Agren, B
    Rudberg, U
    Mare, K
    Aspelin, P
    CLINICAL NUCLEAR MEDICINE, 1997, 22 (02) : 80 - 92
  • [5] Prognostic significance of magnetic resonance imaging (MRI) of bone marrow in previously untreated patients with multiple myeloma.
    Moulopoulos, LA
    Gika, D
    Dellasale, K
    Weber, D
    Anagnostopoulos, A
    Alexanian, R
    Dimopoulos, MA
    BLOOD, 2004, 104 (11) : 415A - 415A
  • [6] DETERMINING THE EXTENT OF DISEASE WITH MAGNETIC RESONANCE IMAGING OF THE BONE MARROW (BM-MRI) IN PATIENTS WITH MULTIPLE MYELOMA
    Ailawadhi, S.
    Abdelhaleim, A. N.
    Derby, L.
    Mashtare, T. L.
    Wilding, G.
    Miller, K. C.
    Gottleib, R.
    Padmanabhan, S.
    Alberico, R. A.
    Klippenstein, D. L.
    Lee, K.
    Chanan-Khan, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 264 - 265
  • [7] Repeatability and reproducibility of apparent diffusion coefficient measurements of bone marrow in magnetic resonance imaging of multiple myeloma patients
    Wennmann, Markus
    Thierjung, Heidi
    Bauer, Fabian
    Groezinger, Martin
    Hielscher, Thomas
    Weru, Vivienn
    Gnirs, Regula
    Sauer, Sandra
    Goldschmidt, Hartmut
    Weinhold, Niels
    Bonekamp, David
    Schlemmer, Heinz-Peter
    Weber, Tim
    Delorme, Stefan
    Rotkopf, Lukas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S48 - S49
  • [8] Prognostic significance of magnetic resonance imaging (MRI) of bone marrow in previously untreated patients with multiple myeloma.
    Dimopoulos, MA
    Moulopoulos, LA
    Delasalle, K
    Weber, D
    Gika, D
    Alexanian, R
    BLOOD, 1999, 94 (10) : 536A - 536A
  • [9] Improved sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in quantifying the extent of bone marrow involvement in patients with Multiple Myeloma (MM)
    Ailawadhi, Sikander
    Derby, Lyudmyla
    Miller, Kena C.
    Mashtare, Terry L.
    Wilding, Gregory
    Padmanabhan, Swaminathan
    Gottlieb, Ronald
    Alberico, Ronald A.
    Klippenstein, Donald L.
    Abdelhalim, Ahmed N.
    Chanan-Khan, Asher A.
    BLOOD, 2007, 110 (11) : 267B - 267B
  • [10] Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients
    Sara Berardo
    Lidiia Sukhovei
    Silvano Andorno
    Alessandro Carriero
    Alessandro Stecco
    La radiologia medica, 2021, 126 : 445 - 452